|Articles|February 1, 2013
- Pharmaceutical Executive-02-01-2013
- Volume 0
- Issue 0
PE, February 2013 Cover Image
S
Advertisement
Cover
Articles in this issue
over 13 years ago
Country Report: Australiaover 13 years ago
Turkey: A Promise Restored?over 13 years ago
NHTSA Addresses "Drugged Driving"over 13 years ago
Fortuity and the First Amendmentover 13 years ago
Oncology: Pathways to Progressover 13 years ago
Pharmaceutical Executive Digital Edition - February 2013Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
2
FDA Approves Lisraya for Adults with Dermatomyositis, Bixlenvo for Virologically Suppressed Adults with HIV, Mounjaro to Reduce MACE in Adults with Type 2 Diabetes
3
M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to Acquire Igalmi from BioXcel
4
Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals
5